Title: Role of ischemia-modified albumin in the early diagnosis of myocardial ischemia
Abstract: Diagnosis on myocardial ischemia is often difficult. The ischemia-modified albumin (IMA) assay presents a quantitative accurate laboratory determination of the occurrence of an iscbemic myocardial event. Unlike previous serum items that identify myocardial damage after the event, this test allows doctors to determine which patient has potential coronary artery lesions before occlusion occurs. Albumin cobalt binding (ACB) test is the assay that measures IMA in human serum, and may be used as an early marker of myocardial iscbemia that occurs prior to myocardial necrosis.
Key words:
ischemia-modified albumin; albumin cobalt binding test; myocardial ischemia
Publication Year: 2008
Publication Date: 2008-12-15
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot